Related Experiment Video
Updated: Jun 29, 2026
09:15
Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells
Published on: May 11, 2020
[Smoking habits among Polish pulmonary physicians]
Damian Korzybski1, Anna Bilska, Ewa Skrzypczyńska
1II Klinika Chorób Płuc Instytutu Gruźlicy i Chorób Płuc w Warszawie. dkorzybski@gmail.com
Pneumonologia I Alergologia Polska
|October 11, 2008
Summary
Smoking prevalence among Polish pulmonary physicians is decreasing but remains higher than in other countries. This highlights the need for continued efforts to reduce smoking habits within the medical community.
Area of Science:
- Pulmonology
- Public Health
- Medical Education
Background:
- Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality, strongly linked to smoking.
- Physicians play a crucial role in public health by setting examples and encouraging smoking cessation.
- Understanding smoking behaviors among specialists is vital for targeted interventions.
Purpose of the Study:
- To evaluate the current smoking habits of Polish pulmonary physicians.
- To identify trends in smoking prevalence within this medical specialty.
Main Methods:
- Anonymous questionnaires were distributed to participants at a Polish Respiratory Society congress in 2006.
- Data collected included age, sex, and smoking status (current smoker, ex-smoker, never smoker).
Main Results:
- A total of 406 pulmonary physicians completed the survey (response rate: 43%).
- Current smokers constituted 10.1% of respondents (13% of men, 9% of women).
- Ex-smokers accounted for 19.5%, and 70.2% were never smokers.
Conclusions:
- The prevalence of smoking among Polish pulmonologists has declined over time.
- Despite the decrease, smoking rates among these specialists are still higher compared to countries with lower general population smoking rates.
More Related Videos
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:25Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...